Ärzteteam

Berger S, Bochum S, Finkeisen D, Schilliro A, Autschbach F, Bischof M, Hagmueller E, Pereira P, Weickert U Sipos, Biskup S, Martens U.
Sustainable response of a patient with metastasized pancreatic cancer and a hypermutational phenotype to immunotherapy. New therapeutic concept for a rare subtype?
JCO Precision Oncology 2018: doi.org/10.1200/PO.18.00005

Roeder F, Lehner B, Saleh-Ebrahimi L, Hensley FW, Ulrich A, Alldinger I, Mechtersheimer G, Huber PE, Krempien R, Bischof M, Debus J, Uhl M
Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases.
Radiother Oncol. 2016 ;119(1):22-9.

Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Lung Cancer. 2016 ;91:41-7.

Sabine Gerum, Falk Roeder, Marc Bischof
Moderne Strahlentherapie des Lungenkarzinoms.
Onkologie heute 01/2016:30-35.

Graeter TP, Sebastian B, Bischof M, Kugler G, Fischer JR, Schneider T
Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
Thorac Cardiovasc Surg. 2015. [Epub ahead of print]

Safi S, Rauch G, op den Winkel J, Kunz J, Schneider T, Bischof M, Heussel CP, Huber PE, Herth FJ, Dienemann H, Hoffmann H
Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.
Respiration. 2015;89(6):550-7.

Roeder F, Ulrich A, Habl G, Uhl M, Saleh-Ebrahimi L, Huber PE, Schulz-Ertner D, Nikoghosyan AV, Alldinger I, Krempien R, Mechtersheimer G, Hensley FW, Debus J, Bischof M
Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis.
BMC Cancer. 2014;14:617. doi: 10.1186/1471-2407-14-617.

Häfner MF, Roeder F, Sterzing F, Krug D, Koerber SA, Kappes J, Hoffmann H, Slynko A, Debus J, Bischof M
Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity.
Strahlenther Onkol. 2015 Feb;191(2):133-40.

Askoxylakis V, Tanner J, Kappes J, Nicolay N, Debus J, Bischof M
Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single centre retrospective analysis.
BMC Cancer 2014;14:572. doi: 10.1186/1471-2407-14-572.

Roeder F, Lehner B, Schmitt T, Kasper B, Egerer G, Sedlaczek O, Grüllich C, Mechtersheimer M, Wuchter P, Hensley FW, Huber PE, Debus J, Bischof M
Excellent Local Control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial.
BMC Cancer 2014;14:350. doi: 10.1186/1471-2407-14-350.

Scharp M, Hauswald H, Bischof M, Debus J, Combs SE
Re-irradiation in the treatment of patients with cerebral metastases of solid tumors: retrospective analysis.
Radiat Oncol 2014 Jan 3;9:4. doi: 10.1186/1748-717X-9-4.

Rief H, Muley T, Bruckner T, Welzel T, Rieken S, Bischof M, Lindel K, Combs SE, Debus J
Survival and prognostic factors in non-small cell lung cancer patients with spinal bone metastases: a retrospective analysis of 303 patients.
Strahlenther Onkol 2014;190:59-63.

Hensley FW, Major G, Edel C, Hauswald H, Bischof M
Technical and dosimetric aspects of the total skin electron beam technique implemented at Heidelberg University Hospital.
Rep Pract Oncol Radiother. 2013;19:135-43. doi: 10.1016/j.rpor.2013.07.002. eCollection 2014.

Rief H, Bischof M, Bruckner T, Welzel T, Askoxylakis V, Rieken S, Lindel K, Combs S, Debus J
The stability of osseous metastases of the spine in lung cancer-a retrospective analysis of 338 cases.
Radiat Oncol. 2013 Aug 13;8(1):200. doi: 10.1186/1748-717X-8-200.

Preusch MR, Baeuerle M, Albrecht C, Blessing E, Bischof M, Katus HA, Bea F
GDF-15 protects from macrophage accumulation in a mousemodel of advanced
atherosclerosis.
Eur J Med Res 2013 Jun 24;18:19. doi: 10.1186/2047-783X-18-19.

Saleh-Ebrahimi L, Zwicker F, Muenter MW, Bischof M, Lindel K, Debus J, Huber PE, Roeder F
Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer – a retrospective single center analysis.
Radiat Oncol 2013 Jan 24;8:20. doi: 10.1186/1748-717X-8-20.

Bischof M
Non-Hodgkin Lymphome.
In Wannenmacher, Wenz, Debus (Hrsg.): Strahlentherapie.
Springer Verlag Berlin, Heidelberg, New York 2013; 2.Auflage:830-843.

Oertel S, Bischof M
Prinzipien der palliativen Therapie.
In Wannenmacher, Wenz, Debus (Hrsg.): Strahlentherapie.
Springer-Verlag Berlin, Heidelberg, New York 2013; 2.Auflage:1063-1069.

Krempien R, Münter M, Bischof M
Mundhöhlenkarzinome.
In Wannenmacher, Wenz, Debus (Hrsg.): Strahlentherapie.
Springer-Verlag Berlin, Heidelberg, New York 2013; 2.Auflage:443-467.

Hauswald H, Zwicker F, Rochet N, Uhl M, Hensley F, Debus J, Herfarth K, Bischof M
Total skin electron beam therapy as palliative treatment for cutaneous manifestations of advanced, therapy-refractory cutaneous lymphoma and leukemia.
Radiat Oncol 2012 Jul 29;7:118. doi: 10.1186/1748-717X-7-118.

Roeder FF, Schulz-Ertner D, Nikoghosyan AV, Huber PE, Edler L, Habl G, Krempien R, Oertel S, Saleh-Ibrahimi L, Hensley FW, Buechler MW, Debus J, Koch M, Weitz J, Bischof M
A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma.
BMC Cancer 2012 Jul 12;12:287. doi: 10.1186/1471-2407-12-287.

Roeder F, Goetz JM, Habl G, Bischof M, Krempien R, Buechler MW, Hensley FW, Huber PE, Weitz J, Debus J
Intraoperative electron radiation therapy (IOERT) in the management of locally recurrent rectal cancer.
BMC Cancer 2012 Dec 11;12:592. doi: 10.1186/1471-2407-12-592.

Pfannschmidt J, Egerer G, Bischof M, Thomas M, Dienemann H
Lungenmetastasen – Kann die Chirurgie unter kurativer Zielsetzung erfolgen?
Deutsches Ärzteblatt 2012;109:645-651.

Askoxylakis V, Dinkel J, Eichinger M, Stieltjes B, Sommer G, Strauss LG, Dimitrakopoulou-Strauss A, Kopp-Schneider A, Haberkorn U, Huber PE, Bischof M, Debus J, Thieke C
Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small cell lung cancer: the HIL trial.
Radiat Oncol 2012 Sep 14;7:157. doi: 10.1186/1748-717X-7-157.

Lehnhardt M, Schmitt T, Bischof M, Daigeler A, Egerer G
Weichteilsarkome. Aktueller Stand der neoadjuvanten Therapie.
Best Practice Onkologie 2012;7:4-12.

Thiemann M, Oertel S, Ehemann V, Weichert W, Stenzinger A, Bischof M, Weber KJ, Lopez Perez R, Haberkorn U, Kulozik A, Debus J, Huber PE, Blattmann C
In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model.
Radiat Oncol. 2012 Mar 29;7:52. doi: 10.1186/1748-717X-7-52.

Hof H, Oertel S, Debus J, Bischof M
Moderne Strahlentherapie des Lungenkarzinoms.
Onkologie heute 2012;3:

Hauswald H, Jensen A, Bischof M
Welche Bestrahlungsart ist bei Kopf-Hals-Tumoren am sinnvollsten?
Im Focus Onkologie 2012;15:22.

Bischof M
Radiochemotherapie mit Drittgenerations-Zytostatikum – die Standards bleiben unverändert.
Im Fokus Onkologie 2011;3:20-21.

Schmitt T, Lehner B, Kasper B, Bischof M, Roeder F, Dietrich S, Dimitrakopoulou-Strauss A, Strauss LG, Mechtersheimer G, Wuchter P, Ho AD, Egerer G
A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma.
BMC Cancer. 2011 Dec 7;11:510. doi: 10.1186/1471-2407-11-510.

Lehnhardt M, Schmitt T, Bischof M, Daigeler A, Egerer G
Current state of neoadljuvant therapy of soft tissue sarcoma.
Chirurg 2011;82:995-1000.

Oertel S, Thiemann M, Richter K, Weber KJ, Huber PE, Perez RL, Brons S, Bischof M, Kulozik AE, Ehemann V, Debus J, Blattmann C
Combination of superoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines.
Radiat Oncol. 2011 Sep 20;6:119. doi: 10.1186/1748-717X-6-119.

Toberer F, Werchau S, Bischof M, Büchler M, Enk A, Helmbold P
Merkel-Zell-Karzinom. Ein hochaggressiver Tumor mit möglicher viraler Genese.
Best Practice Oncology 2011,6:14-22.

Roeder, Zwicker F, Saleh-Ebrahimi L, Timke C, Thieke C, Bischof M, Debus J, Huber PE
Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.
Radiat Oncol. 2011 Mar 1;6:22. doi: 10.1186/1748-717X-6-22. 

Toberer F, Werchau S, Bischof M, Büchler M, Enk A, Helmbold P
Merkel cell carcinoma: A highly aggressive tumor with possible viral etiology.
Chirurg 2011;82:653-660.

Askoxylakis V, Thieke C, Pleger ST, Most P, Tanner J, Lindel K, Katus HA, Debus J, Bischof M
Long term survival of cancer patients compared to heart failure and stroke: a systematic review.
BMC Cancer. 2010 Mar 22;10:105. doi: 10.1186/1471-2407-10-105.

Oertel S, Debus J, Hof H, Bischof M
Radiation therapy of lung carcinoma.
Der Radiologe 2010;50:669-674.

Roeder F, Friedrich J, Timke C, Kappes J, Huber P, Krempien R, Debus J, Bischof M
Correlation of patient related factors and dose volume histogram parameters with the onset of radiation pneumonitis in patients with small cell lung cancer (SCLC).
Strahlentherapie Onkologie 2010;186:149-156.

Reinmuth N, Bischof M
Therapie der Knochenmetastasen bei Lungenkrebs.
Ärztliche Praxis Onkologie 2010;2:30-32.

Askoxylakis V, Debus J, Bischof M
Radiotherapy of skin cancers.
Expert Review of Dermatology 2010;5:173-181.

Klenke FM, Abdollahi A, Bischof M, Gebhard MM, Ewerbeck V, Huber PE, Sckell A
Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.
Strahlentherapie Onkologie 2010;187:45-51.

Oertel S, Blattmann C, Rieken S, Jensen A, Combs SE, Huber PE, Bischof M, Kulozik A, Debus J, Schulz-Ertner D
Radiotherapy in the treatment of primary osteosarcoma- a single center experience.
Tumori 2010;96:582-588.

Blattmann C, Oertel S, Thiemann M, Ehemann V, Huber PE, Bischof M, Witt O, Deubzer H, Kulozik A, Debus J, Weber KJ
Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition.
International Journal of Radiation Oncology Biology Physics 2010;78:237-245.

Blattmann C, Oertel S, Schulz-Ertner D, Rieken S, Haufe S, Ewerbeck V, Unterberg A, Karapanagiotou-Schenkel I, Combs SE, Nikoghosyan A, Bischof M, Jakel O, Huber P, Kulozik AE, Debus J
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
BMC Cancer. 2010 Mar 12;10:96. doi: 10.1186/1471-2407-10-96.

Roeder , Timke C, Zwicker F, Thieke C, Bischof M, Debus J, Huber PE
Intensity modulated radiotherapy (IMRT) in benign giant cell tumors – a single institution case series and short review of the literature.
Radiat Oncol. 2010 Feb 26;5:18. doi: 10.1186/1748-717X-5-18.

Roeder F, Timke C, Oertel S, Hensley F, Bischof M, Muenter M, Weitz J, Buchler M, Lehner B, Debus J, Krempien R
Intraoperative electron radiotherapy for the management of aggressive fibromatosis.
International Journal of Radiation Oncology Biology Physics 2010;76:1154-1160.

Sterzing F, Kalz J, Sroka-Perez G, Schubert K, Bischof M, Roder F, Debus J, Herfarth K
Megavoltage CT in helical Tomotherapy- Clinical advantages and limitations of special physical characteristics.
Technol Cancer Res Treat 2009;8:343-352.

Nagy M, Schulz-Ertner D, Bischof M, Welzel T, Hof H, Debus J, Combs SE
Long-term outcome of postoperative irradiation in patients with newly diagnosed WHO grade III anaplastic gliomas.
Tumori 2009;95:317-324.

Bischof M
Improved survival with postoperative radiotherapy in patients with Merkel cell carcinoma.
Cancer World 2008;22:46-47.

Combs SE, Wagner J,  Bischof M, Welzel T, Edler L, Rausch R, Wagner F,  Zabel-du Bois A, Debus J, Schulz-Ertner D.
Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens.
International Journal of Radiation Oncology Biology Physics 2008; 71:999-1005.

Krempien R, Hoppe H, Daeuber S, Kahrs L, Schorr O, Bischof M, Grehn C, Debus J, Harms W
Projector-based augmented reality for intuitive intraoperative guidance in image guided 3D-interstitial brachytherapy.
International Journal of Radiation Oncology Biology Physics 2008; 70:944-952.

Combs SE, Kelter V, Welzel T, Behnisch W, Kulozik AE, Bischof M, Hof H, Debus J, Schulz-Ertner D
Influence of radiotherapy treatment concept on the outcome of patients with localized ependymomas.
International Journal of Radiation Oncology Biology Physics 2008;71:972-978.

Combs SE, Nagy M, Edler L, Rausch R, Bischof M, Welzel T, Debus J, Schulz -Ertner D
Comparative evaluation of radiochemotherapy with temozolomide versus standard-of-care postoperative radiation alone in patients with WHO grade III astrocytic tumors.
Radiotherapy and Oncology 2008;88:177-182.

Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J, Schulz-Ertner D
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.
Journal of Neurooncology 2008;89:205-210.

Combs SE, Wagner J,  Bischof M, Welzel T, Wagner F,  Debus J, Schulz-Ertner D
Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.
International Journal of Radiation Oncology Biology Physics 2008;70:987-992.

Weisser H, Hartschuh W, Greiner A, Bischof M, Enk A, Helmbold P
Merkel cell carcinoma.
Aktuelle Dermatologie 2008;34:163-169.

Funk A, Hensley F, Krempien R, Neuhof D, van Kampen M, Treiber M, Roeder F, Timke C, Herfarth K, Helmbold P, Debus J, Bischof M.
Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
Eur J Dermatol 2008 ;18:308-312.

Bischof M
Does adjuvant radiotherapy increase survival in patients with Merkel cell carcinoma of the skin?
Nature Clinical Practice Oncology 2007;4:622-623.

Bischof M, Karagiozidis M, Krempien R, Treiber M, Neuhof N, Debus J, Zierhut D.
Radiotherapy for orbital lymphoma: outcome and late effects.
Strahlentherapie Onkologie 2007;183:17-22.

Bischof M, Krempien R, Debus J, Treiber M.
Postoperative electron beam radiotherapy for keloids: objective findings and patient’s satisfaction in self-assessment.
International Journal of Dermatology  2007;46: 971-975.

Bischof M, Zierhut D, Neuhof D, Karagiozidis M, Treiber M, Roeder F, Debus J, Krempien R
Indolent stage IE non-Hodgkin’s lymphoma of the orbit: results after primary radiotherapy.
Ophthalmologica 2007; 221:348-52.

Roeder F, Krempien R, Sterzing F, Funk A, Treiber M, Debus J, Bischof M
Radiotherapy for localised and advanced Merkel cell carcinoma of the skin: a single institution case series.
European Journal of Dermatology 2007;17:229-233.

Bischof M, Debus J, Herfarth K, Muley T, Kappes J, Storz K, Hoffmann H
Surgery and chemotherapy for small cell lung cancer in stages I-II with or without radiotherapy.
Strahlentherapie Onkologie 2007; 183:679-84.

Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J
Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy.
International Journal of Radiation Oncology Biology Physics 2007;67:1411-1417.

Roeder F, Treiber M, Oertel S, Dinkel J, Timke C, Funk A, Garcia-Huttenlocher H , Bischof M, Weitz J, Harms W, Hensley FW, Buchler MW, Debus J, Krempien R
Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer.
International Journal of Radiation Oncology Biology Physics 2007; 67:1381-1388.

Neuhof D, Bischof M, Debus J, Weber KJ
Telomerase activity in peripheral blood mononuclear cells after whole body irradiation.
Oncology Report 2007;17:865-869.

Weisser H, Hartschuh W, Greiner A, Bischof M, Enk A, Helmbold P
Merkel cell carcinoma- clinically often misjudged.
Deutsche Medizinische Wochenschrift 2007;132:1581-1586.

Bischof M, Schubert K, Wannenmacher M, Abdul Latif Al Khal, Saad Al Kaabi, Debus J, Treiber M
Opening the first Radiotherapy Department in the State of Qatar (Middle East) – a challenge.
Strahlentherapie Onkologie 2006;182:123.

Bischof M, Wannenmacher M, Debus J, Treiber M
Aufbau der ersten Strahlentherapie in Qatar.
Eine Kooperation des Universitätsklinikums Heidelberg mit dem Emirat am Persischen Golf.
Deutsches Ärzteblatt, online Ausgabe; 15. August 2006:1-2.

Bischof M, Wannenmacher M, Debus J, Treiber M
The first Radiotherapy Department in Qatar.
GATE  Journal of the German Chamber of Commerce 2006;1:54.

Bischof M
Non-Hodgkin Lymphome.
In Wannenmacher, Debus, Wenz (Hrsg.): Strahlentherapie.
Springer Verlag Berlin, Heidelberg, New York. 2006; 1.Auflage:684-703.

Oertel S, Bischof M
Prinzipien der palliativen Therapie.
In Wannenmacher , Debus ,Wenz (Hrsg.): Strahlentherapie.
Springer-Verlag Berlin, Heidelberg, New York 2006; 1.Auflage:881-886.

Krempien R, Münter M, Bischof M
Mundhöhlenkarzinome.
In Wannenmacher , Debus ,Wenz (Hrsg.): Strahlentherapie.
Springer-Verlag Berlin, Heidelberg, New York 2006; 1.Auflage:382-406.

Krempien R, Roeder F, Oertel S, Roebel M, Weitz J, Hensley F, Timke C, Funk A, Bischof M, Niethammer AG, Eble MJ, Buchler MW, Treiber M, Debus J
Long-term results of intraoperative presacral electron boost radiotherapy (IOERT) in combination with total mesorectal excision (TME) and chemoradiation in patients with locally advanced rectal cancer.
International Journal of Radiation Oncology Biology Physics 2006;66:1143-1151.

Oertel S, Krempien R, Lindel K, Zabel A, Milker-Zabel S, Bischof M, Lipson K, Peschke P, Debus J, Abdollahi A, Huber P
Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and Imitanib (Gleevec).
Strahlentherapie Onkologie 2006;182:400-407.

Huber PE* and Bischof M*, Peschke P, Heiland S, Jenne J, Saffri    ch R, Trinh T, Weber KJ, Gröne HJ, Debus J, Lipson KE, Abdollahi A
Trimodal cancer treatment: beneficial effects of combined antiangiogenesis, radiation and chemotherapy.
Cancer Research 2005;65:3643-3655.
*teilen Erstautorschaft

Treiber M, Oertel S., Weitz J, Krempien R, Bischof M., Wannenmacher M, Büchler M., Debus J
Intraoperative radiotherapy  for rectal carcinoma.
Recent Results in Cancer Research 2005;165:238-244.

Bischof M, Abdollahi A, Gong P, Stoffregen C, Lipson KE, Debus J, Weber KJ, Huber PE
Triple combination of irradiation, chemotherapy (pemetrexed) and VEGF inhibition (SU5416) in human endothelial and tumor cells.
International Journal of Radiation Oncology Biology Physics 2004;60:1220-1232.

Treiber, M, Lehnert T, Oertel S, Krempien R, Bischof M, Büchler M, Wannenmacher M, Debus J
Intraoperative Radiotherapy (IORT) - Special Focus: Recurrent Rectal Carcinoma.
Frontiers of Radiation Therapy and Oncology 2004;38:52-56.

Bischof M, Latz D, Stoffregen C, Wannenmacher M, Weber KJ
Radiosensitizing by pemetrexed of human colon carcinoma cells in different cell cycle phases.
International Journal of Radiation Oncology Biology Physics 2003,57:289-292.

Bischof M, Wannenmacher M
Radiotherapie. Zur Entwicklung der Strahlentherapie von Bronchialkarzinomen.
In: Management des Lungenkarzinoms. Drings, Dienemann, Wannenmacher (Hrsg.):
Springer Verlag Berlin, Heidelberg, New York 2003:172-175.

Abdollahi A, Lipson K, Sckell A, Zieher H, Klenke F, Bischof M, Hahnfeldt P, Gröne HJ, Debus J, Hlatky L, Huber PE
Combined therapy with direct and indirect angiogenesis inhibitors results in enhanced anti-angiogenic and anti-tumor effects.
Cancer Research  2003;63:8890-8898.

Bischof M, Weber KJ, Blatter J, Wannenmacher M, Latz D
Interaction of Pemetrexed disodium (Alimta, Multi Targeted Antifolate) and irradiation in vitro.
International Journal of Radiation Oncology Biology Physics 2002;52:1381-1388.

Bischof M, Zierhut D, Gutwein S, Hansmann J, Stremmel W, Müller M, Wannenmacher M
Die Venenverschlusskrankheit der Leber nach infradiaphragmaler, total lymphatischer Bestrahlung.
Strahlentherapie und Onkologie 2001;177:296-301.

Huber PE, Debus J, Latz D, Zierhut D, Bischof M, Wannenmacher M, Engenhart-Cabilic R
Radiotherapy for advanced adenoid cystic carcinoma:neutrons, photons or mixed beam?
Radiotherapy and Oncology 2001;59:161-167.

Bischof M, Kampen v M, Huber P, Wannenmacher M
Merkel cell carcinoma: The role of radiation therapy in general management.
Strahlentherapie und Onkologie 1999:175:611-616.

Bischof M, Latz D, Wannenmacher M
Metastases to the thyroid: Two cases and a review of the literature.
Onkologie 1999;22:231-234.

Bischof M, Major J, Christ G, Becker G, Nüsslin F
Treatment planning for bicentric stereotactic irradiation.
Radiotherapy and Oncology 1996;38:77-80.

Bischof M, Major J, Christ G, Becker G, Schlattinger B, Nüsslin F
Untersuchungen zur bizentrischen stereotaktischen Konvergenzbestrahlung.
Strahlentherapie und Onkologie 1995;171:340-347.